Effect of famotidine on hospitalized patients with COVID-19: A systematic review and meta-analysis
<h4>Introduction</h4> Famotidine is a competitive histamine H2-receptor antagonist most commonly used for gastric acid suppression but thought to have potential efficacy in treating patients with Coronavirus disease 2019 (COVID-19). The aims of this systematic review and meta-analysis ar...
Guardado en:
Autores principales: | Leonard Chiu, Max Shen, Chun-Han Lo, Nicholas Chiu, Austin Chen, Hyun Joon Shin, Elizabeth Horn Prsic, Chin Hur, Ronald Chow, Benjamin Lebwohl |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/91d5b09a4c2648db86fca9cf1a96cd79 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of famotidine on hospitalized patients with COVID-19: A systematic review and meta-analysis.
por: Leonard Chiu, et al.
Publicado: (2021) -
The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication
por: Madeline Loffredo, et al.
Publicado: (2021) -
Tizanidine-induced acute severe cystitis in a female taking famotidine
por: Poudel RR, et al.
Publicado: (2015) -
Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor
por: Upreti VV, et al.
Publicado: (2013) -
DEVELOPMENT AND VALIDATION OF A REVERSED-PHASE HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF DICYCLOMINE HYDROCHLORIDE AND FAMOTIDINE IN BULK AND TABLETS
por: DONDA,SHAILESH T, et al.
Publicado: (2014)